Allogene Therapeutics Treasury Stock 2018-2025 | ALLO

Allogene Therapeutics treasury stock from 2018 to 2025. Treasury stock can be defined as common shares bought back by the issueing company and held in its treasury

Allogene Therapeutics Treasury Stock 2018-2025 | ALLO

Allogene Therapeutics treasury stock from 2018 to 2025. Treasury stock can be defined as common shares bought back by the issueing company and held in its treasury
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$229.4B
Amgen (AMGN)$163.2B
Gilead Sciences (GILD)$142.1B
Vertex Pharmaceuticals (VRTX)$120.3B
Bristol Myers Squibb (BMY)$95.4B
CSL (CSLLY)$86B
GSK (GSK)$76.9B
Regeneron Pharmaceuticals (REGN)$60.3B
Alnylam Pharmaceuticals (ALNY)$43.1B
Argenex SE (ARGX)$36.6B
BioNTech SE (BNTX)$26.8B
Royalty Pharma (RPRX)$21B
Insmed (INSM)$19.9B
Biogen (BIIB)$18.7B
Illumina (ILMN)$17.2B
Incyte (INCY)$15B
Genmab (GNMSF)$14.7B
Genmab (GMAB)$14.5B
Moderna (MRNA)$12.6B
QIAGEN (QGEN)$11.4B
BioMarin Pharmaceutical (BMRN)$11.2B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Ascendis Pharma (ASND)$10B
Exelixis (EXEL)$9.9B
Bio-Techne Corp (TECH)$9.1B
Exact Sciences (EXAS)$9B
Verona Pharma American Depositary Share (VRNA)$9B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.8B
Legend Biotech (LEGN)$7.5B